EA004256B1 - БЕЛОК, СВЯЗЫВАЮЩИЙСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ, КОДИРУЮЩИЙ ЕГО ПОЛИНУКЛЕОТИД И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ - Google Patents

БЕЛОК, СВЯЗЫВАЮЩИЙСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ, КОДИРУЮЩИЙ ЕГО ПОЛИНУКЛЕОТИД И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ Download PDF

Info

Publication number
EA004256B1
EA004256B1 EA199900941A EA199900941A EA004256B1 EA 004256 B1 EA004256 B1 EA 004256B1 EA 199900941 A EA199900941 A EA 199900941A EA 199900941 A EA199900941 A EA 199900941A EA 004256 B1 EA004256 B1 EA 004256B1
Authority
EA
Eurasian Patent Office
Prior art keywords
protein
fragment
cdna molecule
sequence
polynucleotide
Prior art date
Application number
EA199900941A
Other languages
English (en)
Russian (ru)
Other versions
EA199900941A1 (ru
Inventor
Бредли Элтон Озенбергер
Эйлин Мари Кажковски
Джек Стивен Джекобсен
Джонатан Адам Бард
Стефен Гленн Волкер
Хейди Софиа
Original Assignee
Уайт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Уайт filed Critical Уайт
Publication of EA199900941A1 publication Critical patent/EA199900941A1/ru
Publication of EA004256B1 publication Critical patent/EA004256B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EA199900941A 1997-04-16 1998-04-14 БЕЛОК, СВЯЗЫВАЮЩИЙСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ, КОДИРУЮЩИЙ ЕГО ПОЛИНУКЛЕОТИД И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ EA004256B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6458397P 1997-04-16 1997-04-16
PCT/US1998/007462 WO1998046636A2 (en) 1997-04-16 1998-04-14 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME

Publications (2)

Publication Number Publication Date
EA199900941A1 EA199900941A1 (ru) 2000-06-26
EA004256B1 true EA004256B1 (ru) 2004-02-26

Family

ID=22056941

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900941A EA004256B1 (ru) 1997-04-16 1998-04-14 БЕЛОК, СВЯЗЫВАЮЩИЙСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ, КОДИРУЮЩИЙ ЕГО ПОЛИНУКЛЕОТИД И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ

Country Status (18)

Country Link
EP (1) EP0975753A2 (no)
JP (3) JP2001523093A (no)
KR (1) KR20010006393A (no)
CN (2) CN1196785C (no)
AU (1) AU740445B2 (no)
BR (1) BR9808562A (no)
CA (1) CA2286484A1 (no)
EA (1) EA004256B1 (no)
EE (1) EE9900482A (no)
GE (1) GEP20043386B (no)
HU (1) HUP0003116A3 (no)
ID (1) ID24914A (no)
IL (3) IL132236A0 (no)
NO (1) NO995062L (no)
NZ (1) NZ500216A (no)
SK (1) SK143299A3 (no)
UA (1) UA72875C2 (no)
WO (1) WO1998046636A2 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787319B2 (en) * 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
US7005295B1 (en) 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
JP2002527064A (ja) * 1998-10-13 2002-08-27 アメリカン・ホーム・プロダクツ・コーポレイション ６−蛋白結合受容体様蛋白、それらによりコードされるポリヌクレオチド、ならびにそれらの使用方法
US6455082B1 (en) * 1999-04-26 2002-09-24 Nestec S.A. Shelf-stable calcium fortified milk and dairy products
WO2001029225A1 (en) * 1999-10-21 2001-04-26 Panorama Research, Inc. A general method for optimizing the expression of heterologous proteins
US8663650B2 (en) 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
US7807171B2 (en) 2003-07-25 2010-10-05 Ac Immune Sa Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
US9289488B2 (en) 2010-08-12 2016-03-22 Ac Immune Sa Vaccine engineering
WO2012055933A1 (en) 2010-10-26 2012-05-03 Ac Immune S.A. Liposome-based construct comprising a peptide modified through hydrophobic moieties
CN102060912B (zh) * 2010-11-22 2012-11-14 清华大学 淀粉样蛋白寡聚体构象型抗原表位多肽及其应用
CN111320678B (zh) * 2020-03-09 2023-06-09 安亭生物有限责任公司 抗菌肽突变体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0332640A1 (en) * 1986-11-17 1989-09-20 California Biotechnology, Inc. Recombinant alzheimer's amyloid protein
IL115743A0 (en) * 1994-10-28 1996-01-19 American Nat Red Cross A mammal with cells containing a transgene and its production
US5786180A (en) * 1995-02-14 1998-07-28 Bayer Corporation Monoclonal antibody 369.2B specific for β A4 peptide

Also Published As

Publication number Publication date
EE9900482A (no) 2000-06-15
GEP20043386B (en) 2004-02-10
JP2008104465A (ja) 2008-05-08
KR20010006393A (ko) 2001-01-26
HUP0003116A2 (hu) 2001-01-29
IL132236A0 (en) 2001-03-19
CN1690203A (zh) 2005-11-02
UA72875C2 (uk) 2005-05-16
SK143299A3 (en) 2000-09-12
NZ500216A (en) 2001-06-29
IL132236A (en) 2007-03-08
BR9808562A (pt) 2000-05-23
CN1268973A (zh) 2000-10-04
CN1196785C (zh) 2005-04-13
CA2286484A1 (en) 1998-10-22
NO995062L (no) 1999-12-14
JP2008253275A (ja) 2008-10-23
EA199900941A1 (ru) 2000-06-26
ID24914A (id) 2000-08-31
WO1998046636A3 (en) 1999-01-28
NO995062D0 (no) 1999-10-15
JP2001523093A (ja) 2001-11-20
IL179047A0 (en) 2007-03-08
EP0975753A2 (en) 2000-02-02
WO1998046636A2 (en) 1998-10-22
AU7115698A (en) 1998-11-11
HUP0003116A3 (en) 2003-03-28
AU740445B2 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
JP5562640B2 (ja) ヒト固形腫瘍における遺伝子欠失及び突然変異ａｌｋキナーゼ
KR100499600B1 (ko) 신생 세포 성장을 억제하기 위한 방법 및 조성물
JP4260778B2 (ja) 腫瘍の治療のための組成物と方法
AU2003200722B2 (en) Compositions and methods for the treatment of tumor
JP6144247B2 (ja) ヒト非小細胞肺癌における転座および変異ｒｏｓキナーゼ
EP1220905A2 (en) Composition and methods for the treatment of immune related diseases
JP2002518010A (ja) ９４個のヒト分泌タンパク質
EP1560597A2 (en) Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
JP2002533058A (ja) ９７個のヒト分泌タンパク質
CA2378182C (en) Compositions and methods for the treatment of tumors
EA004256B1 (ru) БЕЛОК, СВЯЗЫВАЮЩИЙСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ, КОДИРУЮЩИЙ ЕГО ПОЛИНУКЛЕОТИД И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ
KR20020008123A (ko) 종양 치료용 조성물 및 방법
KR20010103576A (ko) 종양 치료용 조성물 및 치료 방법
JP2000511765A (ja) 精製ＳＲ―ｐ７０タンパク質
KR20010102960A (ko) 종양 치료용 조성물 및 방법
WO2006082826A1 (ja) Corl2遺伝子を標的としたプルキンエ細胞識別方法
JP6740172B2 (ja) ヒト固形腫瘍における遺伝子欠失及び突然変異ａｌｋキナーゼ
JP2002504361A (ja) ３６個のヒト分泌タンパク質
WO2003102028A1 (fr) Proteine induite par le gene rb1 (rb1cc1) et gene
AU776063C (en) Compositions and methods for the treatment of tumor
WO2001005836A1 (en) Polypeptidic compositions and methods for the treatment of tumors
JP6141224B2 (ja) ヒト固形腫瘍における遺伝子欠失及び突然変異ａｌｋキナーゼ
KR20010102996A (ko) 메그-4 단백질
JP2020156481A (ja) ヒト固形腫瘍における遺伝子欠失及び突然変異ａｌｋキナーゼ
EP1820860A2 (en) Methods and compositions for inhibiting neoplastic cell growth

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU